REQUEST A DEMO
Total
USD $0.00
Search more companies

Shanghai Haishun New Pharmaceutical Packaging Co., Ltd. (China)

Main Activities: Plastics Packaging Materials and Unlaminated Film and Sheet Manufacturing
Full name: Shanghai Haishun New Pharmaceutical Packaging Co., Ltd. Profile Updated: April 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Shanghai Haishun New Pharmaceutical Packaging Co., Ltd. is a national high-tech enterprise located in Shanghai. The company specializes in the research, production, and sales of high barrier packaging materials for direct contact with pharmaceuticals. Since its establishment, the company has been dedicated to providing pharmaceutical companies with comprehensive drug packaging solutions that are moisture-proof, oxygen-proof, light-proof, and child-resistant. They continuously conduct research and development, transformation, and professional market services for pharmaceutical packaging materials. Through independent research and development, the company has successfully achieved high barrier properties, high ductility, and strong weather resistance in new pharmaceutical packaging materials such as cold stamping aluminum. After scaling up production, they have become a well-known enterprise in this segment of the market. The DMF files of their main products have been registered with the US FDA, qualifying their products to enter the European and American markets. In 2011, the company became a designated partner of Honeywell's Aclar products. The company places great emphasis on product research and development and maintains stable collaborative relationships with Donghua University and Jiangnan University. Their affiliated Engineering Technology Research Center has been recognized by the Suzhou Science and Technology Bureau as the "Suzhou Pharmaceutical Packaging New Material Engineering Technology Research Center."

Headquarters
18 Caijiabin Road Dongjing Town Songjiang District Shanghai
Shanghai; Shanghai; Postal Code: 201103

Contact Details: Purchase the Shanghai Haishun New Pharmaceutical Packaging Co., Ltd. report to view the information.

Website: http://www.hysum.com

Basic Information
Total Employees:
Purchase the Shanghai Haishun New Pharmaceutical Packaging Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Shanghai Haishun New Pharmaceutical Packaging Co., Ltd. report to view the information.
Registered Capital:
Purchase the Shanghai Haishun New Pharmaceutical Packaging Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Shanghai Haishun New Pharmaceutical Packaging Co., Ltd. report to view the information.
Incorporation Date:
January 18, 2005
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
29.98%
Purchase this report to view the information.
16.65%
Purchase this report to view the information.
2.82%
Purchase this report to view the information.
1.21%
Purchase this report to view the information.
0.73%
Subsidiaries
Haishun Europe GMBH
100%
Shanghai Haishun Medical New Material Co., Ltd.
100%
Suzhou Haishun Packaging Materials Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Shanghai Haishun New Pharmaceutical Packaging Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-0.56%
Total operating revenue
1.14%
Operating profit (EBIT)
-9%
EBITDA
-12.54%
Net Profit (Loss) for the Period
-16.55%
Total assets
-0.66%
Total equity
3.92%
Operating Profit Margin (ROS)
-1.12%
Net Profit Margin
-1.85%
Return on Equity (ROE)
-0.32%
Debt to Equity Ratio
-2.95%
Quick Ratio
0.01%
Cash Ratio
-0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?